Research News and Research

RSS

Stay Fresh textiles technology from Quick-Med

Quick-Med Technologies, Inc. (OTCBB:QMDT) announced today the development of a proprietary Stay Fresh™ technology and that the Company is seeking partners to commercialize this revolutionary new technology in key segments of the textile market.

23 Sep 2009

ART's new generation Optix MX3 optical molecular imaging system unveiled

ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today unveiled a new generation of its optical molecular imaging system, called Optix® MX3, at the Industry Workshop opening event of the World Molecular Imaging Congress.

23 Sep 2009

Alimera Sciences starts pilot study of Iluvien intravitreal insert

Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien(R) in patients with macular edema secondary to retinal vein occlusion.

23 Sep 2009

First Edition: September 23, 2009

Today's headlines mark the opening day of the Senate Finance Committee's health bill mark up as well as a new round up of changes to the chairman's mark.

23 Sep 2009

New drug test promises to yield quick and effective response for cancer therapy

A group of scientists from Hamburg may have taken a big step towards more effective cancer drug development, Europe's largest cancer congress, ECCO 15 - ESMO 34 [1], heard today (Wednesday 23 September). Dr Ilona Schonn, Director of Cell Culture Research at Indivumed GmbH, told the conference that they had developed a preclinical drug test platform that would enable researchers to analyse tumour tissue for individual patient drug responses on the molecular level.

23 Sep 2009

Improved respiratory health in Mexican women who use vented stoves

Women in Central Mexico who used a vented stove instead of the traditional indoor open fire, experienced improved respiratory health on par with a pack-a-day smoker kicking the habit, according to a recent study.

23 Sep 2009

Second annual study of FDA drug review released

PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL) and a leading global life sciences consultancy serving the biopharmaceutical and medical device industries, today released its second annual study on the state of the U.S. Food and Drug Administration (FDA) drug review process.

From Parexel 23 Sep 2009

GE Healthcare creates a digital wall to commemorate the tenth anniversary of digital mammography

In addition to being Breast Cancer Awareness Month, this October is the tenth anniversary of digital mammography, a technology introduced by GE Healthcare (NYSE:GE) in 1999. Similar to digital photography, digital mammography replaces the film used in traditional mammography with digital files viewed and stored on computers.

23 Sep 2009

CANCER Research UK updates its patient information website

CANCER Research UK is to unveil its revamped award-winning patient information website, CancerHelp UK (www.cancerhelp.org.uk), in November.

23 Sep 2009

Winner of the 2009 ECNP Neuropsychopharmacology Award

The European College of Neuropsychopharmacology (ECNP) is pleased to announce Jean-Pol Tassin as the recipient of the 2009 ECNP Neuropsychopharmacology Award in Basic Science Research in recognition of his pioneering and innovative research into the neurochemical basis of substance addiction.

23 Sep 2009

Agilent Technologies introduces SureSelect Human All Exon Kit

Agilent Technologies Inc. (NYSE:A) has chosen the Cambridge Health Institute’s Next-Generation Sequencing Analysis conference today to introduce its SureSelect Human All Exon Kit for target enrichment prior to next-generation DNA sequencing.

23 Sep 2009

ESMO recognises outstanding achievements of leading cancer specialists

The European Society for Medical Oncology (ESMO) has recognized the outstanding achievements of three leading cancer specialists with its three prestigious annual awards: the 2009 ESMO Award, Hamilton Fairley Award and ESMO Lifetime Achievement Award.

23 Sep 2009

New TAXUS Liberté Stent demonstrates superior results for treating long lesions

Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS(R) Liberté(R) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberté Stent when compared to the first-generation TAXUS(R) Express(R) Stent.

23 Sep 2009

Agilent Technologies and Applied Biosystems to co-market SureSelect system

Agilent Technologies Inc. (NYSE:A) and Applied Biosystems, part of Life Technologies Corp. (NASDAQ:LIFE), today introduced the Agilent SureSelect Target Enrichment System, which is optimized for the SOLiD™ System, a next-generation advanced genomic analysis sequencing platform.

23 Sep 2009

Utah medical ethics expert chairs NIH review of embryonic cells

University of Utah medical ethics expert Jeffrey R. Botkin will chair a federal panel that will review scientists' requests to conduct government-funded research using embryonic stem cells left over from couples who used "test-tube fertilization" to have babies.

23 Sep 2009

Dust Alert sensor to monitor quality of air

Worried that dust from a nearby construction zone will harm your family's health? A new Tel Aviv University tool could either confirm your suspicions or better yet, set your mind at rest.

23 Sep 2009

NIH funding helps to boost sales of DNA sequencers

Rapid increase in output from second-generation DNA sequencers has enabled new levels of productivity and new experiments. This, along with funding from the stimulus bill, has caused rapid adoption of these machines, according to healthcare market research firm Kalorama Information, helping to fuel sales of DNA sequencers to $480 million in 2008. In its report "DNA Sequencing Equipment and Services Markets, 2nd Edition," Kalorama says more changes are on the way and will drives sales growth of 19% annually through 2013.

23 Sep 2009

EU-U.S. trans-disciplinary research agenda for synthetic biology

The Wilson Center's Synthetic Biology project recently received two grants from the National Science Foundation. One will support a Transatlantic Exploratory Workshop on the Implications of Cutting-Edge Biotechnologies for Sustainability Science and Policy, and the other will support research on the use of on-line prediction markets to explore emerging issues in synthetic biology.

23 Sep 2009

Technological and scientific initiatives from Helicos BioSciences Corporation

Helicos BioSciences Corporation provided updates on recent scientific findings and progress on Helicos’s technology initiatives. Speaking at the Personal Genomes conference in Cold Spring Harbor, NY, and the CHI Next Generation Sequencing conference in Providence, RI, Patrice Milos, Ph.D. Vice President and Chief Scientific Officer provided an overview of recent technological and scientific initiatives underway at Helicos.

23 Sep 2009

Melanoma patients could be spared from unnecessary surgery

Researchers have shown for the first time that patterns of ultrasound signals can be used to identify whether or not cancer has started to spread in melanoma patients, and to what extent. The discovery enables doctors to decide on how much surgery, if any, is required and to predict the patient's probable survival.

23 Sep 2009